Keyphrases
Type 2 Diabetes Mellitus (T2DM)
59%
Matched Cohort Study
56%
COVID-19
51%
Adjusted Hazard Ratio
41%
Population-based Cohort Study
36%
Meta-analysis
32%
People Living with HIV (PLHIV)
27%
Population-based
26%
Propensity Score Matching
25%
Systematic Meta-analysis
23%
Incidence Rate
23%
High Risk
23%
Birth Weight
21%
Autoimmune Disease
21%
Diabetes
20%
All-cause Mortality
19%
Primary Care
19%
During Pregnancy
16%
Cardiovascular Disease
16%
Patients with Diabetes
16%
Chronic Kidney Disease
15%
Living with
15%
Dyslipidemia
14%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
14%
China
13%
Mortality Risk
13%
Hypertension
13%
United Kingdom
13%
Metformin
13%
Maternal Lipid Levels
12%
Retrospective Cohort Study
12%
Clinical Practice Research Datalink
12%
Antidiabetic Drugs
12%
Anonymized
12%
Type 2 Diabetic Patients
12%
Confidence Interval
12%
Dementia
11%
Population-based Retrospective Cohort Study
11%
Noninvasive Ventilation
10%
Care Pathway
10%
Type 2 Diabetes Diagnosis
10%
Generalisability
10%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
10%
Low-middle Income Countries
10%
Sight-threatening Diabetic Retinopathy
10%
Lessons Learned
10%
Endometriosis
10%
Brazil
10%
Socioeconomic Deprivation
10%
Hospital Services
10%
Medicine and Dentistry
Cohort Analysis
90%
Maturity Onset Diabetes of the Young
69%
Systematic Review
69%
Meta-Analysis
44%
COVID-19
32%
Human Immunodeficiency Virus
32%
Diabetes
29%
Hazard Ratio
26%
Retrospective Cohort Study
23%
Birth Weight
21%
Diabetic Retinopathy
21%
Autoimmune Disease
21%
Cardiovascular Disease
19%
Chronic Kidney Disease
18%
Prevalence
17%
Diseases
15%
Glycon
14%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Dyslipidemia
13%
Antidiabetic Agent
12%
Patient with Type 2 Diabetes
11%
Signal Detection
10%
Nonalcoholic Fatty Liver
10%
Accelerated Aging
10%
Low and Middle Income Countries
10%
Cord Blood
10%
Endometriosis
10%
Endocrinology
10%
Noninvasive Ventilation
10%
Cohort Effect
10%
Network Meta-Analysis
10%
Impaired Glucose Tolerance
10%
Pregnancy Complication
10%
Cardiovascular System
10%
Prematurity
10%
Foot Disease
10%
Atrial Fibrillation
10%
Chronic Obstructive Pulmonary Disease
10%
Gestational Diabetes
10%
Care Pathway
10%
Gene Linkage
10%
Umbrella Review
10%
Bariatric Surgery
10%
Body Mass Index
10%
Primary Health Care
9%
Proportional Hazards Model
8%
Randomized Controlled Trial
7%
Comorbidity
7%
Obstetrics
7%
Odds Ratio
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Non Insulin Dependent Diabetes Mellitus
51%
Diseases
29%
Dyslipidemia
22%
HIV
21%
All Cause Mortality
19%
Cardiovascular Disease
16%
Metformin
14%
sodium glucose cotransporter-2 inhibitors
14%
Chronic Kidney Failure
13%
Triacylglycerol
12%
Adverse Outcome
12%
Prevalence
12%
Antidiabetic Agent
12%
Sodium Glucose Cotransporter 2 Inhibitor
10%
Nonalcoholic Fatty Liver
10%
Non-Steroidal Anti-Inflammatory Drug
10%
Pregnancy Diabetes Mellitus
10%
Chronic Obstructive Lung Disease
10%
Renin-Angiotensin System Inhibitor
10%
Dipeptidyl Carboxypeptidase
10%
Pharmacovigilance
10%
Endometriosis
10%
Polypharmacy
10%
High Density Lipoprotein Cholesterol
10%
Angiotensin 1 Receptor Antagonist
10%
Base
10%
Foot Disease
10%
Case-Control Study
10%
Autoimmune Disease
10%
Pregnancy Complication
10%
Diabetic Retinopathy
10%
Sleep Disordered Breathing
10%
Randomized Controlled Trial
10%
Calcium Channel Blocker
8%
Coronavirinae
7%
Comorbidity
6%
Adverse Event
5%
Peptidase
5%
